Understanding Hyperopia (Farsightedness) and the Role of Infrared Light Therapy
Hyperopia, commonly known as farsightedness, is a refractive error where distant objects can be seen more clearly than close objects. This condition occurs when the eyeball is too short or the cornea is too flat, causing light rays to focus behind the retina instead of directly on it. There are different types of hyperopia, including simple hyperopia, which is typically present from birth and may remain stable throughout life; progressive hyperopia, where the degree of farsightedness increases over time; and functional hyperopia, which can occur due to factors such as accommodation dysfunction or eye muscle imbalances.
Diagnosis of hyperopia involves a comprehensive eye examination by an optometrist or ophthalmologist, including visual acuity testing, refraction assessment, and evaluation of the eye's anatomy and structure. Additional tests such as keratometry, corneal topography, or optical coherence tomography (OCT) may be performed to determine the degree of hyperopia and assess any associated ocular complications. Early detection and intervention are crucial for managing hyperopia effectively and preventing potential vision-related complications.
The Retyne Infrared Eye Treatment Mask offers a potential therapeutic solution for managing the symptoms of hyperopia. Program #2 on the Retyne controller delivers invisible infrared light therapy directly to the eyes, targeting the underlying mechanisms contributing to hyperopia progression. By utilizing infrared light therapy, the Retyne mask aims to promote relaxation of the ciliary muscles, improve accommodative ability, and enhance near vision in individuals with hyperopia. This non-invasive approach provides a comfortable and convenient option for addressing the visual deficits associated with hyperopia, complementing traditional treatments such as corrective lenses, vision therapy, or refractive surgery.
Through the utilization of program #2 on the Retyne controller, the Retyne mask delivers targeted infrared light therapy to the eyes, offering potential improvement in visual function for individuals with hyperopia. By harnessing the power of invisible infrared light, Retyne's innovative approach aims to mitigate the progression of hyperopia and optimize visual outcomes. Further research and clinical studies are necessary to fully evaluate the efficacy and long-term benefits of infrared light therapy in the management of hyperopia, but early evidence suggests that the Retyne Infrared Eye Treatment Mask holds promise as a valuable therapeutic tool in this context.
The Retyne eye treatment mask harnesses a series of frequencies (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5 ) specifically tailored for addressing Hyperopia (Farsightedness). These frequencies have been carefully selected for their efficacy in managing and treating this condition.
Retyne's approach involves translating each frequency into invisible infrared light output, representing a novel integration of frequencies with light, a pioneering technology developed by Retyne Labs. This innovative method draws inspiration from the pioneering work of Dr. Rife, who identified specific frequencies with healing properties and utilized a light source for their transmission. Building upon current research on invisible infrared technology and leveraging past studies on light transmission via frequency sources, the Retyne eye treatment mask represents a fusion of cutting-edge advancements in the field.
Moreover, for those utilizing advanced hardware such as the RDPV4, a secondary set of specific frequencies for Hyperopia (Farsightedness) (0.1, 0.57, 0.95, 12.85, 20, 37.7, 95.79, 250, 475.58, 527 ) is available. The RDPV4 offers an expanded range of frequencies, finely calibrated to provide even greater precision in addressing Hyperopia (Farsightedness). By incorporating this secondary set of frequencies, the RDPV4 elevates the potential therapeutic benefits of the Retyne eye Treatment Mask, catering to individuals seeking advanced solutions for their visual health needs.
Hyperopia (Farsightedness) General Group exists at program 1233 on the International ETDFL frequency list
Hyperopia (Farsightedness) Specific Group exists at program 1704: 0.1, 0.57, 0.95, 12.85, 20, 37.7, 95.79, 250, 475.58, 527
Compatibility
Standalone controller (Program #2) (Controller shipped with Retyne Eye Treatment Mask)
RDPV4 (Direct connect, use group 1704)
RDPV4 Light Mask Program button 2
Click here for instructions on using the Retyne Mask + Controller
